BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37341987)

  • 1. Machine learning models predict the mTOR signal pathway-related signature in the gastric cancer involving 2063 samples of 7 centers.
    Zhang H; Zhuo H; Hou J; Cai J
    Aging (Albany NY); 2023 Jun; 15(13):6152-6162. PubMed ID: 37341987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMOD1, an oncogene associated with Lauren classification, regulates the metastasis of gastric cancer cells through the FAK-AKT/mTOR pathway.
    Tan Y; Chen Q; Pan S; An W; Xu H; Xing Y; Zhang J
    BMC Cancer; 2022 Apr; 22(1):474. PubMed ID: 35488236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines.
    Riquelme I; Tapia O; Espinoza JA; Leal P; Buchegger K; Sandoval A; Bizama C; Araya JC; Peek RM; Roa JC
    Pathol Oncol Res; 2016 Oct; 22(4):797-805. PubMed ID: 27156070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of autophagy-related genes in the PI3K/Akt/mTOR pathway and risk of gastric cancer in the Chinese population.
    Zheng W; Wu C; Wu X; Cai Y; Liu B; Wang C
    Gene; 2021 Feb; 769():145190. PubMed ID: 33053421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses.
    Li J; Qiao H; Wu F; Sun S; Feng C; Li C; Yan W; Lv W; Wu H; Liu M; Chen X; Liu X; Wang W; Cai Y; Zhang Y; Zhou Z; Zhang Y; Zhang S
    Front Immunol; 2022; 13():998140. PubMed ID: 36275774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids.
    Koh V; Chakrabarti J; Torvund M; Steele N; Hawkins JA; Ito Y; Wang J; Helmrath MA; Merchant JL; Ahmed SA; Shabbir A; Yan So JB; Yong WP; Zavros Y
    Cancer Lett; 2021 Oct; 518():59-71. PubMed ID: 34126195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway.
    Sun D; Zhang M; Wei M; Wang Z; Qiao W; Liu P; Zhong X; Liang Y; Chen Y; Huang Y; Yu W
    Aging (Albany NY); 2022 May; 14(9):3887-3909. PubMed ID: 35507914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of mTOR pathway with risk of gastric cancer in male smoker with potential prognostic significance.
    Ghosh P; Alam N; Mandal S; Mustafi SM; Murmu N
    Mol Biol Rep; 2020 Oct; 47(10):7489-7495. PubMed ID: 32918126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
    Liu J; Cheng Z
    Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
    Hibdon ES; Razumilava N; Keeley TM; Wong G; Solanki S; Shah YM; Samuelson LC
    Neoplasia; 2019 Jul; 21(7):702-712. PubMed ID: 31129492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLI1 overexpression promotes gastric cancer cell proliferation and migration and induces drug resistance by combining with the AKT-mTOR pathway.
    Yao Y; Zhou D; Shi D; Zhang H; Zhan S; Shao X; Sun K; Sun L; Wu G; Tian K; Zhu X; He S
    Biomed Pharmacother; 2019 Mar; 111():993-1004. PubMed ID: 30841479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M-Phase Phosphoprotein 9 upregulation associates with poor prognosis and activates mTOR signaling in gastric cancer.
    Xu LL; Shang Y; Qu XN; He HM
    Kaohsiung J Med Sci; 2021 Mar; 37(3):208-214. PubMed ID: 33174370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of machine learning-based integration to develop an immune-related signature for improving prognosis in patients with gastric cancer.
    Ning J; Sun K; Fan X; Jia K; Meng L; Wang X; Li H; Ma R; Liu S; Li F; Wang X
    Sci Rep; 2023 Apr; 13(1):7019. PubMed ID: 37120631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of GOLPH3 associated with the progression of gastric cancer: a preliminary study.
    Peng J; Fang Y; Tao Y; Li K; Su T; Nong Y; Xie F; Lai M
    PLoS One; 2014; 9(10):e107362. PubMed ID: 25286393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition.
    Liao KF; Chiu TL; Huang SY; Hsieh TF; Chang SF; Ruan JW; Chen SP; Pang CY; Chiu SC
    Cell Physiol Biochem; 2018; 48(6):2231-2246. PubMed ID: 30114701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.